OraSure surges on FDA approval for HIV-2 saliva test
This article was originally published in Clinica
Executive Summary
Shares in OraSure Technologies soared yesterday after the US FDA gave it the all-clear to sell its 20-minute saliva test for the HIV-2 virus.